Skip to content

Observational Study to see the process of recovery from Anaesthesia while monitoring muscle contraction using Neuromuscular monitoring system

Role of neuromuscular monitoring for the judicious use of Neuromuscular blockers and the reversal agents.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/06/008841
Enrollment
200
Registered
2017-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients posted for general surgical proceudres of less than 2 hours duration under general anaeshtesia.

Interventions

Control Intervention1: Objective Neuromuscular Monitoring (NMT): In a prospective cohort study we observed the use of objective neuromuscular monitoring in assessing adequate muscle relaxation for int

Sponsors

RESEARCH CELL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The primary outcome of the study was the time required to achieve TOF ratio of 0.9 at the end of surgery, without giving neostigmine while extubating the patients at TOF ratio of 0.9.

Exclusion criteria

Exclusion criteria: 1) The patients with history of diabetes, myasthenia gravis. 2) The patients with hepato-renal impairment. 3) Patients having surgery at the site where electrodes were to be applied 4) All types of emergency surgeries.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study was the time required to achieve TOF ratio of 0.9 at the end of surgery, without giving neostigmine and extubating the patients at TOF ratio of 0.9.Timepoint: TOF ratio of 0.9

Secondary

MeasureTime frame
The secondary outcome measures were incidence of post-operative residual curarization (PORC) in post anaesthesia care unit (PACU) when neostigmine was not given for reversal, incidence of reintubation in PACU, incidence of nausea, vomiting in PACU and time required to shift the patients from PACU to wards, when neostigmine is not used for reversing NMB at the end of surgery.Timepoint: PACU: 0 to 2 hrs

Countries

India

Contacts

Public ContactShilpa Goyal

All India Institute of Medical Sciences Jodhpur

goyals@aiimsjodhpur.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026